These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 7308629

  • 1. [Effects of 1-alpha-hydroxyvitamin D 3 treatment of osteodystrophy in uremic patients treated with periodic hemodialysis].
    Palmieri P, Albertazzi A, Cappelli P, Di Paolo B.
    G Clin Med; 1981 Jul; 62(7):443-60. PubMed ID: 7308629
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effects of 1 alpha-(OH)D3 on renal osteodystrophy--a 5-year retrospective evaluation].
    Kakuhara T, Mizoguchi M, Itoh M, Nagasawa M, Mori T, Ohtsuka K, Kubota M, Minatoguchi T, Ohara K, Yoshida M, Koide H, Ohno J.
    Nihon Jinzo Gakkai Shi; 1982 Jun; 24(6):693-704. PubMed ID: 7176180
    [No Abstract] [Full Text] [Related]

  • 7. Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease.
    Teitelbaum SL.
    Ann Intern Med; 1981 Mar; 94(3):404-5. PubMed ID: 6894359
    [No Abstract] [Full Text] [Related]

  • 8. [Use of "active" vitamin D in uremic osteodystrophy].
    Tarchini R, Mioli V, Baldelli S, Figus S, Pacchiarotti P.
    Minerva Med; 1982 Oct 20; 73(40):2775-8. PubMed ID: 6290945
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Photonic densitometry for the diagnosis of the uremic osteodystrophy.
    Bordoni E, Baldelli S, Bibiano L, Bichi Secchi E, Lombardi M, Lombardo V, Micucci G, Procaccini G, Mioli V.
    Life Support Syst; 1985 Oct 20; 3 Suppl 1():503-6. PubMed ID: 3870615
    [No Abstract] [Full Text] [Related]

  • 11. [Clinico-morphological correlations in uremic osteodystrophy of patients with conservative and hemodialytic treatment with special regard to the ultrastructure].
    Bonucci E, Gherardi G, Mioni G, Castellani A, Cecchettin M, Cristinelli L, Migozzi G, Maiorca R, Maschio G, D'Angelo A, Ossi E, Lupo A, Valvo E.
    Minerva Nefrol; 1975 Oct 20; 22(2-3):99-108. PubMed ID: 1226257
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Differential effects of 1,25-hydroxycholecalciferol in uremic osteodystrophy].
    Tarchini R, Pacchiarotti P, Figus S, Perilli A, Baldelli S, Mioli V.
    Minerva Nefrol; 1981 Oct 20; 28(2):147-50. PubMed ID: 6895244
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Aluminum associated bone disease in patients undergoing long-term hemodialysis].
    Hino M, Yamamoto I, Shigeno C, Aoki J, Torizuka K, Iwamoto N, Yamazaki S, Fukuda T, Kondo M, Yamamoto N.
    Nihon Naibunpi Gakkai Zasshi; 1986 Jun 20; 62(6):724-36. PubMed ID: 3758431
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Recommendations for the treatment of renal osteodystrophy in dialysis patients.
    Slatopolsky E.
    Kidney Int Suppl; 1975 Jan 20; (2):253-5. PubMed ID: 169423
    [No Abstract] [Full Text] [Related]

  • 20. [Intracortical tunnels: an early sign of hyperparathyroidism in chronic uremia under periodic hemodialysis].
    Meneghello A, Camposampiero A, Corbetti F, Bertoli M.
    Radiol Med; 1983 Sep 20; 69(9):650-3. PubMed ID: 6672850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.